Trends in inpatient complications after transcatheter and surgical aortic valve replacement in the transcatheter aortic valve replacement era

TY - JOUR

T1 - Trends in inpatient complications after transcatheter and surgical aortic valve replacement in the transcatheter aortic valve replacement era

AU - Arora, Sameer

AU - Strassle, Paula D.

AU - Qamar, Arman M.D.

AU - Kolte, Dhaval

AU - Pandey, Ambarish

AU - Paladugu, Madhu B.

AU - Borhade, Mahesh B.

AU - Ramm, Cassandra J.

AU - Bhatt, Deepak L.

AU - Vavalle, John P.

N1 - Funding Information: funded by Daiichi Sankyo), Population Health Research Institute; Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org; Vice-Chair, ACC Accreditation Committee), Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; RE-DUAL PCI clinical trial (Randomized Evaluation of Dual Antithrombotic Therapy With Dabigatran Versus Triple Therapy With Warfarin in Patients With Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention) steering committee funded by Boehringer Ingelheim), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), HMP Global (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Guest Editor; Associate Editor), Population Health Research Institute (for the Cardiovascular Outcomes for People Using Anticoagulation Strategies [COMPASS] operations committee, publications committee, steering committee, and USA national coleader, funded by Bayer), Slack Publications (Chief Medical Editor, Cardiology Today’s Intervention), Society of Cardiovascular Patient Care (Secretary/Treasurer), WebMD (CME steering committees); Other: Clinical Cardiology (Deputy Editor), National Cardiovascular Disease Registry-ACTION Registry Steering Committee (Chair), Veterns Affairs Clinical Assessment Reporting and Tracking (VA CART) Research and Publications Committee (Chair); Research Funding: Abbott, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Idorsia, Ironwood, Ischemix, Lilly, Medtronic, PhaseBio, Pfizer, Regeneron, Roche, Sanofi Aventis, Synaptic, The Medicines Company; Royalties: Elsevier (Editor, Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease); Site Co-Investigator: Biotronik, Boston Scientific, St Jude Medical (now Abbott), Svelte; Trustee: American College of Cardiology; Unfunded Research: FlowCo, Merck, Novo Nordisk, PLx Pharma, Takeda. Dr Qamar is supported by the National Heart, Lung, and Blood Institute T32 postdoctoral training grant (T32HL007604), the American Heart Association Strategically Focused Research Network in Vascular Disease grant (18SFRN3390085 & 18SFRN33960262), research grants to his institution from Daiichi Sankyo and fees for CME programs from Medscape. P.D. Strassle has received salary support from researchEZ LLC, and Dr Arora’s spouse has proprietary role in researchEZ LLC. C.J. Ramm serves on an advisory board for Boston Scientific. The other authors report no conflicts.

PY - 2018

Y1 - 2018

KW - Acute kidney injury

KW - Blood transfusion

KW - Incidence

KW - Mortality

KW - Transcatheter aortic valve replacement

UR - http://www.scopus.com/inward/record.url?scp=85058911000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058911000&partnerID=8YFLogxK

U2 - 10.1161/CIRCINTERVENTIONS.118.007517

DO - 10.1161/CIRCINTERVENTIONS.118.007517

M3 - Letter

C2 - 30571211

AN - SCOPUS:85058911000

SN - 1941-7640

VL - 11

JO - Circulation: Cardiovascular Interventions

JF - Circulation: Cardiovascular Interventions

IS - 11

M1 - e007517

ER -